Covid19
Study finds treatment for critical COVID-19 patients – The Jerusalem Post
COVID-19 patients who suffer from ARDS were given a treatment of an anti-inflammatory protein in a phase 2 clinical trial.
COVID-19 patients who suffer from ARDS were given a treatment of an anti-inflammatory protein in a phase 2 clinical trial.
